- Home
- Solutions
- By Disease
- Systemic Mitochondrial Disease
- Alpers Disease
- Barth Syndrome
- Carnitine Deficiency
- Creatine Deficiency Syndromes
- Co-Enzyme Q10 Deficience
- Friedreich’s Ataxia
- Kearns-Sayre Syndrome
- Lactic Acidosis
- Leigh Syndrome
- Mitochondrial DNA Depletion Syndrome
- MELAS Syndrome
- Multiple Mitochondrial Dysfunction Syndrome
- Short-Chain Acyl-CoA Dehydrogenase Deficiency
- Thymidine Kinase 2 Deficiency
- Mitochondrial Neurogastrointestinal Encephalopathy
- Organ-specific Mitochondrial Diseases
- Systemic Mitochondrial Disease
- By Applications
- Mitochondrial Disease Diagnostics Service
- Therapeutics Development Services for Mitochondrial Diseases
- Mitochondrial Disease Target Development & Identification Service
- Mitochondrial Disease Model Development Service
- Drug Development Service for Mitochondrial Diseases
- In Vitro Mitochondrial Analysis Service
- In Vivo Mitochondrial Fission and Fusion Analysis
- By Molecular Type
- By Disease
- Resource
- About Us
- Contact Us
- Careers
Resources
Online Inquiry
Genetically Engineering Model Development for Barth Syndrome
Protheragen's highly experienced and talented researchers, scientists, and collaborators are experts at advanced genetic engineering model development for various mitochondrial diseases (e.g., Barth syndrome) and are committed to furthering insights into these complex diseases and customized therapies through innovative animal model development techniques.
Applications of Genetically Engineering Models in Barth Syndrome
Biomarker Identification and Mechanistic Studies: Custom genetically engineered animal models may offer unique opportunities to elucidate key biomarkers for the disease and facilitate mechanistic investigations to probe the underlying biological processes that shape disease pathophysiology.
Drug Discovery and Development: Barth syndrome animal models have been established and serve important roles in drug discovery initiatives in terms of screening potential therapeutics and providing a basis for early-stage research that allows researchers to assess the effectiveness of promising agents.

Optional Animal Model for Barth Syndrome
- Taz-KO Model Development
- Taz-Flox Model Development
- Taz-KD Model Development
- Taz-CKO Model Development
Believing that our capabilities in generating Barth syndrome genetic engineering models provide a powerful and flexible resource for researchers interested in advancing mitochondrial disease research and drug discovery, we also provide services for developing cell-based and other animal models for different mitochondrial diseases. Should our services pique your interest, we invite you to contact us to delve into our customized solutions.
For research use only, not for clinical use.
Resource Download Request
Please complete the form to download the requested resources.